Ted W. Love - 02 Feb 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Director
Signature: /s/ Edward S. Son by Power of Attorney for Ted W. Love
Issuer symbol: GILD
Transactions as of: 02 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 06 Feb 2024, 18:01:38 UTC
Previous filing: 06 Feb 2024
Next filing: 09 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Award	$0	+512		$0.000000	512	02 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Non-qualified Stock Option (Right to Buy)	Award	$0	+2,996		$0.000000	2,996	02 Feb 2024	Common Stock	2,996	$76.96	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 512 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of February 2, 2024.
F2	100% of the shares subject to the stock option vested immediately upon the grant date of February 2, 2024.